◆英語タイトル:Helomics Corp - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C6639
◆発行会社(調査会社):
GlobalData
◆発行日:2018年10月
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
GlobalData社の概要はこちらでご確認いただけます。
【レポートの概要】
Summary
Helomics Corp (Helomics) is a life science company that develops and offers precision medicine support tools and services for cancer treatment. The company’s products include chemofx, biospecifx, genefx colon and genefx lung. Its chemofx is a drug response marker, which is used to test tumor response to various chemotherapeutic and biologic agents. Helomics’ biospecifx is a biomarker that is used to test drug response and patient prognosis. The company also offers contract research, genefx colon, which is a microarray-based gene signature that identifies patients at risk of recurrence. It serves clinical testing, precision medicine and cancer research needs of physicians. The company has operations in US and Canada. Precision is headquartered in Pittsburgh, Pennsylvania, the US.
Helomics Corp – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.
Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Helomics Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Helomics Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Helomics Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Helomics Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Helomics Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Helomics Corp, Medical Equipment, Deal Details 10
Venture Financing 10
Precision Therapeutics Raises US$14 Million In Venture Financing 10
Private Equity 11
Healthcare Royalty Invests USD60 Million in Precision Therapeutics 11
Partnerships 12
Skyline Medical Forms Joint Venture with Helomics 12
Skyline Medical and Helomics Enter into Partnership 13
Helomics Partners with MDNA Life Sciences 14
Acquisition 15
Precision Therapeutics to Acquire Remaining 75% Stake in Helomics 15
Precision Therapeutics Acquires 25% Stake in Helomics 16
Helomics Corp – Key Competitors 17
Helomics Corp – Key Employees 18
Helomics Corp – Locations And Subsidiaries 19
Head Office 19
Recent Developments 20
Strategy And Business Planning 20
Jun 01, 2017: Helomics and the Pittsburgh Life Sciences Greenhouse Partner to Establish a Biotechnology Incubator Dedicated to Diagnostics and Precision Medicine 20
Corporate Communications 21
Jan 10, 2018: Helomics Announces the appointment of Dr. Marc Malandro to its Advisory Board, providing strategic insights for the Skyline Medical – Helomics Joint Venture 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22
List of Tables
Helomics Corp, Medical Equipment, Key Facts 2
Helomics Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Helomics Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Helomics Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Helomics Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Helomics Corp, Deals By Market, 2012 to YTD 2018 8
Helomics Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Precision Therapeutics Raises US$14 Million In Venture Financing 10
Healthcare Royalty Invests USD60 Million in Precision Therapeutics 11
Skyline Medical Forms Joint Venture with Helomics 12
Skyline Medical and Helomics Enter into Partnership 13
Helomics Partners with MDNA Life Sciences 14
Precision Therapeutics to Acquire Remaining 75% Stake in Helomics 15
Precision Therapeutics Acquires 25% Stake in Helomics 16
Helomics Corp, Key Competitors 17
Helomics Corp, Key Employees 18
List of Figures
Helomics Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Helomics Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Helomics Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Helomics Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Helomics Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Helomics Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Helomics Corp, Medical Equipment, Deals by Market, 2012 to YTD 2018 8